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1078–5884/00Compliance Matching Stent Placement in the Carotid Artery
of the Swine Promotes Optimal Blood Flow
and Attenuates Restenosis
P.H. Rolland,1* C. Mekkaoui,1 V. Vidal,1,2 J.L. Berry,4 J.E. Moore,5 M. Moreno,5
P. Amabile1,3 and J.M. Bartoli1,2aLaboratory of Hemodynamics and Cardiovascular Mechanics, School of Medicine, Departments of bRadiology,
LaTimone-Hospital, cVascular Surgery, Sainte-Marguerite-Hospital, Marseille, France, dBiomedical
Engineering, Wake Forest University Health Sciences, Winston-Salem, NC, and eBiomedical Engineering,
Texas A&M University, College Station, Texas, USAObjectives. We assessed the value of a gradient-compliant stent in an animal model.
Methods. Bilateral carotid arteries were stented with nitinol stents having variable-oversizing, variable-stiffness, and with
(CMS, 10 animals) and without (SMART, four animals) compliance-matching endings. Angiography, hemodynamic,
scanning-electron-microscopic and histological analyses were performed at 3-month. The protocol was completed in 14
among 19 swines.
Results. Transient (1-month) exaggerated recoil, attributable to stress-induced phasic inhibition of vasorelaxation,
developed at CMS endings. At mid-term, all stents were endothelialized; CMS-stents, but not SMART-stents, were
incorporated into walls (one-strut-thickness). Restenosis developed outside SMART-stents (cell migrationCwall-
compensatory enlargement) whereas CMS-stents elicited no or focalized cell-accumulations at endings that bulged
vascular walls radially outward. SMART-stents were blood-flow neutral, whereas CMS-stents favored (higher-stiffness,
higher-oversizing) or opposed (lower-stiffness, less-oversizing) carotid blood flow.
Conclusions.Direct carotid stenting with stents having compliance-matched endings and specific requirements of stiffness
and oversizing can optimize blood flow to the brain and restrict local restenosis.Keywords: Stents; Carotid arteries; Blood-flow; Cerebrovascular disorders.Carotid stenting has been associated with transient
ischaemic attack or stroke in 5–10% of patients.1–4 One
of the causes of stroke following endovascular carotid
intervention is cerebral hyperperfusion syndrome
with intracerebral hemorrhage.5 With improved
understanding of brain hemodynamics and the
response of the artery to stenting, we were interested
in developing an improved stent for use in the carotid
circulation.6–16
We previously performed in vitro and in vivo
investigations on how the stent/artery hybrid struc-
ture creates disturbances in normal hemodynamics
(flow and pressure waves) and wall stress distribution
(leading to deleterious re-organization of vascular
tissue).17–20 Specifically, the observed hemodynamic
disturbances were primarily accounted for by abrupting author. Pierre-Henri Rolland, LHMCV, School of
, BdJean-Moulin, 13385 Marseille Cedex 5, France.
: ph.rolland@medecine.univ-mrs.fr (P.H. Rolland).
0431 + 08 $35.00/0 q 2004 Elsevier Ltd. All rights resercompliance mismatch at the junction between stent
endings and host arterial wall. Since stents are
typically more rigid than the artery into which they
are placed, they represent an impedance mismatch to
the forward-moving waves of flow and pressure.
Reduction of this mismatch led to development of
the compliance matching stent (CMS). The wall
circumferential stress was reduced compared to a
non-CMS and the CMS prevented dampening of flow/
pressure waves upstream and downstream of the stent
in swine iliac arteries. Transposing these observations
to the carotid arterial bed will potentially improve
clinical and angiographic outcomes by facilitating
blood flow through the stented segment and minimiz-
ing wall stress and thus the subsequent cellular
reactions from within to outside the stenting site in
adjacent vascular walls.
In an attempt to optimize clinical and restenotic
outcomes of direct stenting in the carotids, the presentEur J Vasc Endovasc Surg 28, 431–438 (2004)
doi:10.1016/j.ejvs.2004.06.018, available online at http://www.sciencedirect.com onved.
P. H. Rolland et al.432study investigated angiographic, histomorphometric
and flow consequences in carotid arteries of adding
compliance matching endings to a self-expanding
stent.Materials and MethodsExperimental protocol
Institutional Ethics Committee approval for the pro-
tocol was granted. Nineteen adult (6-months, 55G
5 kg) Pietrin swines (Blossin SA, Aubagne/France)
were anaesthetized with ketamine (15 mg/kg, IM),
followed by midazolam (0.5 mg 10 mlK1 minK1) in
Ringer-Lactate solution.21,22 Intravenous epigastric
line, ECG leads, and SaO2/plethysmographic tail-
probe (HP78354C, Hewlett–Packard) were placed for
monitoring. Antibiotics (amoxicillin-clavulanic acid,
1 g:200 mg in 20 ml, IV) were given twice. Euthanasia
was performed by midazolam (50 mg/10 ml), and KCl
(25 ml, 20%, IV). All stents used were based on the
nitinol SMART stent (Cordis Corp, Miami, FL) and
were considered non-compliance matching because of
uniform rigidity across their length. Compliance
matched stents were fabricated such that proximal
and distal ends of stent had flexible extensions that
flexed with the arterial wall at the transition zone.17–20
Two different stiffnesses of each stent type were
created: stiffer and less stiff stents were denoted S1
and S2, respectively. The stents were selected based on
nominal vascular oversizing in a range from 0 to 40%.
Either the CMS or SMART stents were implanted with
different stiffness in ipsi- and contra-lateral sides,
respectively. Angiography was performed at day 0
(pre- and post-procedure), day 1, day 3, week 1, month
1 and month 3 (explantation). Animals were submitted
to hemodynamic investigations prior to euthanasia,
then to carotid sampling for histologic examinations.Radiologic procedures, stent implantations
All procedures were performed using a digitized-
subtraction Stenoscop system (General-Electric-
Medical-System, Mineapolis, USA).19,22 A 11 cm-long
6F vascular sheath (Cordis-Corp, Miami, FL) was
inserted in the distal SFA (Seldinger-method). For
stent implantation, sodium-heparin (5000 IU in 1 ml
bolus) was given IV. Angiograms were obtained from
custom-made angiographic catheters (5F, 100 cm, tip
with 1 cm-distant radiopaque markers, 8 ml, 5 ml sK1,
Hexabrix, Guerbet) and advanced over a 0.035 in
guidewire (Terumo). Delivery devices, SMART stentsEur J Vasc Endovasc Surg Vol 28, October 2004and CMS stents (30 mm in length, and 5, 6, 7 and 8 mm
in nominal diameter) were manufactured, cleaned and
sterilized with ethylene-oxide using the same methods
by the same operators (Nitinol-Devices and Com-
ponents, Cordis-Corp, Fremont, CA) stiffness S1 and
S2 were fixed through the temperature of the nitinol
martensitic transformation (Af 16–18 8C and Af 28–
30 8C, respectively), the radial strength (chronic out-
ward force) was 0.30 and 0.60 N/cm, respectively,
which are above and below the 0.45 N/cm averaged
value for arterial walls.23,24 Following compressive
haemostasis at the puncture site, animals were
transferred back to facilities.Hemodynamics
The carotid arteries were dissected through oblique
cervical incision.19,21,22,25 Pulsatile blood pressure was
measured with 2F Mikro-Tip catheter pressure trans-
ducer SPR-249 (Millar Instruments, Inc., Houston),
and pulsatile flow with T206-blood-flowmeter
(Transonic Systems, Inc., Ithaca, NY) and perivascular
RB flowprobes. Measurements were performed under
fluoroscopic guidance 1 cm above and below stents, at
proximal and distal stent endings, and midstent
locations. Hemodynamic data were acquired (AT-
MIOSX data-acquisition-card, LabView, National
Instruments, Austin, TX) and denoted as systolic
(Qmax), diastolic (Qmin), mean (Qmean) and pulse
(DQ) flows. Their respective counterparts in pressure
were Pmax, Pmin, Pmean and DP. Reported measure-
ments were averaged from 20 consecutive cycles.Histology, scanning-electron-microscopy, morphometry
Carotid arteries were subjected to repeated washings/
perfusion with pH 7.3, 10% formalin (120-mmHg-
pressure, 15 min), fixed (48 h), and cut-open longitudin-
ally (one-half for SEM, second-half for pathologic
examination).21,26,27 Pathologic slides (3 mm, tungsten–
carbide-knives) were obtained after alcoholic dehydra-
tation-embedding in LR-Whitehardgrade resins
(London-Resin Company, Hants, UK). SEM examin-
ations were with a Quanta200-SEM (FEI company,
Eindhoven, Netherlands) under low vacuum mode.
The measurements performed were wall thickness
(expressed as percentage of thickness in unscathed
distant vascular walls) and estimates of stent-strut
internalization within the vascular wall (location of
parietal, bottom side of mid-stent struts within wall,
defined as mid-stent covering (midstentcov), expressed
as percentage of strut thickness).
The Compliance Matching Stent in Carotids 433Statistical analysis
Statistical analyses were performed by using Systat 9.0
software (SPSS Inc, Chicago, IL). Results are expressed
as meanGstandard deviation. Kruskal–Wallis test,
Mann–Whitney U test, and multiple regression
analysis were performed. Statistical significance was
reached for p!0.05.ResultsFig. 2. Angiograms of evolving diameter in carotids with
CMS-S1 (left) and S2 (right) along 3-month follow-up.Animals, stent implantations, angiographic findings
Optimal immediate angiographic results were
obtained in all cases. Two animals died, one at day 1
secondary to deep-venous-thrombosis and one at 2.5
months as a result of pneumonia. Three animals were
excluded from analysis due to non-compliance to the
experimental protocol. At 3 months, 14 animals had
completed the protocol (stent type, stiffness, over-
stretching) and were used for comparison of CMS-S1
versus CMS-S2 (10 cases) and SMART-S1 versus
SMART-S2 (4 cases). Stents were randomly implanted
in right and left carotid arteries. Distributions of stent
types and stiffness, and pre-procedure angiographic
diameters (4.92G0.66 mm) were identical in right and
left arteries. The pre-procedure luminal diameter/
stent nominal diameter ratio (nominal oversizing) was
22.56G11.12%. The quantified changes in carotid
diameters, averaged at mid-stent, proximal and distal
endings (Fig. 1) show that there was no significant
changes in luminal diameter with SMART stents along
the follow-up, although a slight (!10%), non-signifi-
cant, decrease in size was observed in the immediate
post-procedure situation. After CMS implantation,
unexpectedly, a time-dependent reduction in luminal
diameter was observed at both endings of the CMS
stents (from day 0 to 1 month versus initial diameter:
p!0.05) which, after 1 week, was found to be
reversible (day 0 versus 3 months: p!0.05), (Figs. 1
and 2). The CMS stents transition zone reduced inFig. 1. Angiographic diameter of carotids arteries with CMS
or SMART stents with variable stiffness (S1OS2) along 3
months follow-up (averaged values, percentage of post-
procedure diameter). The luminal diameter was derived
from radio-opaque markers on the angiographic catheter.diameter paralleling the luminal diameter, which
could not be attributed to a deficiency in outward
forces of stents since it was more pronounced in S1
(more stiff) than in S2 (less stiff) stents.Scanning electron microscopic and histologic findings
Arteries with SMART stents showed consistent and
moderate upstream thickening of walls which did not
reduce the angiographic diameter, likely due to a
compensatory enlargement-like process (Fig. 3(A)). In
contrast, intimal thickening was found co-located with
the transition zone of the CMS stent endings (Fig.
3(B)). Histological appearance of the stented segment
showed the usual restenotic process (fibrosis and
medial cell proliferation, cell migration and reorienta-
tion along migration pathways, Fig. 4). The restenotic
process developed externally to stent struts prior to
propagation upstream of the stent (Figs. 3(B) and 4),
(and downstream as well, data not shown). There wasEur J Vasc Endovasc Surg Vol 28, October 2004
Fig. 3. SEM in cut-opened carotids with SMART and CMS stents showing restenotic process upstream the SMART stent (A)
and at CMS endings (B) (white arrows); CMS-connecting zone and CMS-S1 plunging into wall (C) (white arrow); endothelial
covering of SMARTwithout stent entering the wall (midstentcov:!5%) (D) (white arrow); stent printings into vascular media
(E).
P. H. Rolland et al.434no relationship between reduction in angiographic
diameter at week 1 and intimal thickening at three
months (r2!0.426). The results indicate that the
angiographic observations were mediated by mech-
anical rearrangement of the vessels which after week 1
led the constricted vessel to return to pre-procedure
diameter.Internalization of stent struts into the vascular walls
SEM analyses of struts internalization into the vessel
wall showed that the struts were covered by the
endothelium monolayer under all circumstances (Fig.
3), and the high or low stiffness SMART stents were
never found internalised into the vessel walls, even
when the artery was overstretched (Figs. 3(D) and 5).
In contrast, the presence of the transition zone in stiff
CMS stents resulted in internalisation of struts to one
strut thickness and also in a manner independent of
overstretching the vessels. Internalization of struts still
resulted in cushioned prints of stents on the luminal
surface, due to accumulating materials in the sub-
endothelial space above the struts (Fig. 3(E)). In the
case of CMS with low stiffness, strut internalisation
was linearly increased by overstretching the artery.Blood flow in stented segments
The mean pressure characteristics in the carotidEur J Vasc Endovasc Surg Vol 28, October 2004arteries stented with CMS (Pmean (108G6 mmHg),
Pmax (128G5 mmHg), Pmin (93G6 mmHg) and DP
(32G7 mmHg) were not statistically different from
those in SMART stented carotids (pO0.75). Similarly,
blood flow in the carotid arteries in which SMART
stents were placed (nominal oversizing 26.5G4.66%)
(447.1G71.7, 520.6G84.6, 329.5G84.4 and 221.5G
68.4 ml/min as Qmean, Qmax, Qmin and DQ, respect-
ively) were not found different from flow in CMS
stented segments at identical overstretching values
(Fig. 6, pO0.70). In contrast, adjunction of the
transition zone strongly influenced blood flow in
stented arteries (Fig. 6). All along the stented segment,
an elevated stiffness increased flow with increased
overstretching (p!0.01), whereas the reverse situation
was observed with low stiffness stents (p!0.05).
Results obtained with CMS-S1 also showed that,
although the mean flow linear relationship was
identical above and below the stent (pO0.76), Qmin
was lowered whereas Qmax was increased (p!0.05).
These indicate that the transition zone facilitated the
transmission of flow waves from upstream to down-
stream of the stent and amplified the pulsatility of flow
waves under constant mean flow.Discussion
Smoothening the mismatch in compliance between the
stent and host carotid artery was expected to improve
Fig. 4. Microphotographs shows the extrusion process (white arrow) and the outward development (black arrow) of
restenosis at proximal endings of CMS stents (upper panel), and (lower panels) the fibrosis/cell proliferation restenotic wall
thickening, and outward development of restenosis which originated from reorientation of proliferating cells from media to
restenotic processes (HES staining).
Fig. 5. Stent plunging into arterial wall are expressed as the
percentage of strut thickness covered by arterial wall,
referred to as midstentcov, for SMART and CMS stents
with elevated or moderate stiffness (S1, S2).
The Compliance Matching Stent in Carotids 435blood flow to downstream brain tissues (beneficial
clinical outcome) and to inhibit local formation of
restenosis (beneficial angiographic outcome). The
mid-term results demonstrate that (i) structural
adducts render the CMS stent capable of favorable
effects on blood flowing through the stented artery, (ii)
the CMS-induced actions are beneficial or deleterious
depending upon device stiffness and nominal over-
sizing, and (iii) the vascular restenotic processes were
reduced and further trapped within the CMS endings.
Angiographic follow-up revealed a transient exagger-
ated elastic recoil and phasic vasoconstriction from the
artery at CMS endings.Eur J Vasc Endovasc Surg Vol 28, October 2004
Fig. 6. Hemodynamics in the carotid segment stented with CMS S1 or S2, as a function of nominal oversizing of the artery at
the time of implantation for maximum (Qmax), minimal (Qmin), pulse (DQ) and mean (Qmean) flows.
P. H. Rolland et al.436Angiographic findings: the recoil of the CMS areas
The close angiographic follow-up revealed early
exaggerated recoil of the CMS endings in the carotid
arteries. Successful stent implantation in patients with
carotid stenoses is obtained with residual stenosis of
10–30% and it is unknown whether elastic recoil
contributed to residual stenosis. Since the recoil
occurred independently from nominal oversizing,
and delayed expansion was not attributable to stent
penetration within the vascular walls, our results
indicate that equilibrium was progressively reached
between stent outward forces and carotid recoil
properties.
The intriguing angiographic features inherent to the
CMS are that the recoil extent largely surpasses the
nominal artery diameter. The vessel constriction
process was not previously observed in the iliac
arteries19 and the differential behaviour laying in
between iliacs and carotids is presumably justified
by the mechanical properties and histological organ-
ization of carotids, having a much greater extent of
thick muscular laminae, as compared with iliacs.24 The
greater number of smooth muscle cells (SMC) may
amplify a contractile process otherwise not detectable.
Otherwise, the recoil process for nitinol stents could
tentatively be explained by the intrinsic characteristics
of martinsitic nitinol13,24,30–33 which does not apply
here because the recoil overpasses the nominalEur J Vasc Endovasc Surg Vol 28, October 2004diameter. The reversible nature of the constriction at
the CMS endings indicated that the process is achieved
by phasic vasoreactive responses rather than by
structural alterations of the vascular walls.Flow findings: the requirements for flow improvements
The pre-procedure intrinsic characteristics of blood
flow in carotid arteries illustrates the functional
requirements for the feeding arteries to the target
organs: although the mean blood flow is similar in the
iliacs and carotids, diastolic flow is much higher in the
carotid arteries and flow pulsatility in the iliacs is
twice that in the carotids.24 A high diastolic flow is a
major brain nutritional requirement, whereas a high
pulsatility is necessary for appropriate blood propul-
sion to the distal part of the lower limbs. The SMART
stent is neutral with regard to its hemodynamics
effects on blood flow, which therefore, means that the
clinical outcome of brain functioning will depend
upon restenosis development at the stented site. The
CMS endings beneficial concept in the carotid arterial
bed only applies when stent stiffness is higher than
native artery, and overall stiffness of stent–wall
complex is reinforced by radial outward forces of
stent aimed at oversizing the artery. Thinner struts
elicit less angiographic and clinical restenosis than
thicker-strut stents, and placement of slotted-tube
stent under non-aggressive conditions blunts
The Compliance Matching Stent in Carotids 437alterations in fluid dynamics during coronary vasodi-
lation in vivo. That a blood flow-dependent expected
beneficial effect can be achieved, with the marked
response of the artery to the CMS endings in the
carotids led to the conclusion that an elastic artery
which restores its baseline levels of strain, requires a
stiff device to be efficient. The results are in line with
our finite element analysis of solid mechanics of the
stent-artery hybrid structure.Restenosis: the trapping of spreading SMC by CMS endings
The unexpected angiographic changes led us to
investigate outstent versus instent wall morphology
along the longitudinal axis by using previously
developed SEM methods, similarly to intravascular
ultrasound (IVUS) methods utilized for studying
arterial remodeling with axial redistribution from the
lesion into the reference segments.11–16 We found
proliferative cell bulks with few fibrotic reactions
were restricted to the CMS endings, bulging out the
vascular walls. Histological analysis displayed images
that the proliferative SMCs tended to be kept ‘in place’
at the CMS stent endings. Proliferative and spreading
SMCs are major factors contributing to restenosis
immediately after stent implantation, whereas long-
term restenosis consists primarily of large amounts of
proteoglycan-rich ECM.41 Our findings that SMC
remained blocked at the CMS endings are tentatively
explained by considering that the compliance match-
ing zone, as having decreasing stiffness from the stent
to the arterial wall inhibits spreading of cells.Conclusions
The present study demonstrates the high sensitivity of
carotid arteries to the mechanical aspects of direct
stenting. Direct stenting in the carotid arterial bed can
favor brain blood flow and restrict local restenotic
processes provided CMS stents fulfill specific require-
ments of physical stiffness and implantation. That
arterial responses may be modulated by changing the
design and physical properties of the stent potentially
is of prominent therapeutic relevance with regards to
optimisation of carotid stenting. Flow and anti-rest-
enotic improvements brought about by introducing
CMS endings in stents can, in conjunction with distal
emboli protection, provide stenting the carotids with
increased safety and efficacy particularly in vulnerable
patients.Acknowledgements
This study was funded by a grant from Cordis Corporation.
The authors gratefully acknowledge the technical assistance
provided by James Silver, PhD, Cordis.References
1 Denny DF. Prediction of restenosis after carotid artery stent
implantation. Radiology 2003;227(2):316–318.
2 Chakhtoura EY, Hobson RW, Goldstein J, Simonian GT,
Lal BK, Haser PB. In-stent restenosis after carotid angioplasty-
stenting: incidence and management. J Vasc Surg 2001;33(2):220–
225.
3 Lal BK, Hobson RW, Goldstein J, Geohagan M,
Chakhtoura E, Pappas PJ. In-stent recurrent stenosis after
carotid artery stenting: life table analysis and clinical relevance.
J Vasc Surg 2003;38(6):1162–1168.
4 Bowser AN, Bandyk DF, Evans A, Novotney M, Leo F,
Back MR. Outcome of carotid stent-assisted angioplasty versus
open surgical repair of recurrent carotid stenosis. J Vasc Surg
2003;38(3):432–438.
5 Hartmann M, Weber R, Zoubaa S, Schranz C, Knauth M.
Fatal subarachnoid hemorrhage after carotid stenting.
J Neuroradiol 2004;31(1):63–66.
6 McCarthy RJ, Nasr MK, McAteer P, Horrocks M. Physio-
logical advantages of cerebral blood flow during carotid
endarterectomy under local anaesthesia. A randomised clinical
trial. Eur J Vasc Endovasc Surg 2002;24(3):215–221.
7 Nielsen MY, Sillesen HH, Jorgensen LG, Schroeder TV. The
haemodynamic effect of carotid endarterectomy. Eur J Vasc
Endovasc Surg 2002;24(1):53–58.
8 Troeng T, Bergqvist D, Norrving B, Ahari A. Eur J Vasc
Endovasc Surg. Complications after carotid endarterectomy are related
to surgical errors in less than one-fifth of cases 1999;18(1):59–64.
9 Hellberg A, Christiansson L, Ulus AT, Bergqvist D,
Wiklund L, Karacagill S. A prolonged spinal cord ischaemia
model in pigs. Passive shunting offers stable central haemody-
namics during aortic occlusion. Eur J Vasc Endovasc Surg 2000;
19(3):318–3233.
10 Bicknell CD, Cheshire NJW. The relationship between carotid
atherosclerotic plaque morphology and the embolic risk during
endovascular therapy. Eur J Vasc Endovasc Surg 2003;26(1):17–21.
11 Ahmed JM, Mintz GS, Weissman NJ, Lansky AJ, Pichard AD,
Satler LF. Mechanism of lumen enlargement during intracor-
onary stent implantation—an intravascular ultrasound study.
Circulation 2000;102(1):7–10.
12 Danzi GB, Fiocca L, Capuano C, Predolini S, Quaini E. Acute
stent recoil: in vivo evaluation of different stent designs. Catheter
Cardiovasc Intervent 2001;52(2):147–153.
13 Carrozza JP, Hosley SE, Cohen DJ, Baim DS. In vivo
assessment of stent expansion and recoil in normal porcine
coronary arteries—differential outcome by stent design. Circula-
tion 1999;100(7):756–760.
14 Mintz G, Pichard AD, Kent KM, Satler LF, Popma JJ,
Leon MB. Axial plaque redistribution as a mechanism of
percutaneous transluminal coronary angioplasty. Am J Cardiol
1996;77:427–430.
15 Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF,
Wong SC. Arterial remodeling after coronary angioplasty: a
serial intravascular ultrasound study. Circulation 1996;94(1):35–
43.
16 Finet G, Weissman NJ, Mintz GS, Satler LF, Kent KM,
Castagna MT. Comparison of luminal enlargement by direct
coronary stenting versus predilation coronary stenting by three-
dimensional volumetric intravascular ultrasound analysis. Am
J Cardiol 2001;88(10):1179–1185.Eur J Vasc Endovasc Surg Vol 28, October 2004
P. H. Rolland et al.43817 Berry JL, Moore JE, Newman VS, Routh WD. In vitro flow
visualisation in stented arterial segments. J Vasc Invest 1997;3:63–
68.
18 Berry JL, Manoach E, Mekkaoui C, Rolland PH, Moore JE,
Rachev A. Hemodynamics and wall mechanics of a compliance
matching stent: in vitro and in vivo analysis. J Vasc Intervent
Radiol 2002;13(1):97–105.
19 Rolland PH, Charifi AB, Verrier C, Bodard H, Friggi A,
Piquet P. Hemodynamics and wall mechanics after stent
placement in swine iliac arteries: comparative results from six
stent designs. Radiology 1999;213(1):229–246.
20 Delfino A, Stergiopulos N, Moore JE, Meister JJ. Residual
strain effects on the stress field in a thick wall finite element
model of the human carotid bifurcation. J Biomech 1997;30(8):777–
786.
21 Rolland PH, Friggi A, Barlatier A, Piquet P, Latrille V,
Faye MM. Hyperhomocysteinemia-induced vascular damage in
the minipig. Captopril-hydrochlorothiazide combination pre-
vents elastic alterations. Circulation 1995;91(4):1161–1174.
22 Rolland PH, Mekkaoui C, Palassi M, Friggi A, Moulin G,
Piquet P. Efficacy of local molsidomine delivery from a hydrogel-
coated angioplasty balloon catheter in the atherosclerotic porcine
model. Cardiovasc Intervent Radiol 2003;26(1):65–72.
23 Mekkaoui C, Friggi A, Rolland PH, Bodard H, Piquet P,
Bartoli JM. Simultaneous measurements of arterial diameter
and blood pressure to determine the arterial compliance, wall
mechanics and stresses in vivo. Eur J Vasc Endovasc Surg 2001;
21(3):208–213.
24 Rosset E, Friggi A, Novakovitch G, Rolland PH, Rieu R,
Pellissier JF et al. Effects of cryopreservation on the viscoelastic
properties of human arteries. Ann Vasc Surg 1996;10(3):262–272.
25 Rolland PH, Bartoli JM, Piquet P, Mekkaoui C, Nott SH,
Moulin G. Local delivery of no-donor Molsidomine post-PTA
improves haemodynamics, wall mechanics and histomorpho-
metry in atherosclerotic porcine SFA. Eur J Vasc Endovasc Surg
2002;23(3):226–233.
26 Piquet P, Rolland PH, Bartoli JM, Tranier P, Moulin G,
Mercier C. Tantalum-Dacron coknit stent for endovascular
treatment of aortic aneurysms: a preliminary experimental
study. J Vasc Surg 1994;19(4):698–706.
27 Ambrosi P, Rolland PH, Bodard H, Barlatier A, Charpiot P,
Guisgand G. Effects of folate supplementation in hyperhomo-
cysteinemic pigs. J Am Coll Cardiol 1999;34(1):274–279.
30 Yasuhara K, Mitsumori K, Shimo T, Onodera H,
Takahashi M, Hayashi Y. Mice with focal pulmonary fibrosis
caused by monocrotaline are insensitive to urethane induction of
lung tumorigenesis. Toxicol Pathol 1997;25(6):574–581.Eur J Vasc Endovasc Surg Vol 28, October 200431 Etave F, Finet G, Boivin M, Boyer JC, Rioufol G, Thollet G.
Mechanical properties of coronary stents determined by using
finite element analysis. J Biomech 2001;34(8):1065–1075.
32 Batchelor WB, Zidar JP. Favorable vascular remodeling from
self-expanding stents: magic or myth? Am Heart J 1999;138:203–
205.
33 Roguin A, Grenadier E, Linn S, Markiewicz W, Beyar R.
Continued expansion of the nitinol self-expanding coronary
stent: angiographic analysis and 1-year clinical follow-up. Am
Heart J 1999;138(2):326–333.
34 Knoepp L, Beall A, Woodrum D, Mondy JS, Shaver E,
Dickinson M. Cellular stress inhibits vascular smooth muscle
relaxation. J Vasc Surg 2000;31(2):343–353.
35 Feder ME, Hofmann GE. Heat-shock proteins, molecular
chaperones, and the stress response: evolutionary and ecological
physiology [review]. Ann Rev Physiol 1999;61:243–282.
36 Flynn CR, Komalavilas P, Tessier D, Thresher J,
Niederkofler EE, Dreiza CM. Transduction of biologically
active motifs of the small heat shock-related protein, HSP20,
leads to relaxation of vascular smooth muscle. FASEB J 2003;
17(8):1204–1212.
37 Connolly EM, Kelly CJ, Chen G, O’Grady T, Kay E, Leahy A.
Pharmacological induction of HSP27 attenuates intimal hyper-
plasia in vivo. Eur J Vasc Endovasc Surg 2003;25(1):40–47.
38 Pache J, Kastrati A, Mehilli J, Schuhlen H, Dotzer F,
Hausleiter J. Intracoronary stenting and angiographic results:
strut thickness effect on restenosis outcome (ISAR-STEREO-2)
trial. J Am Coll Cardiol 2003;41(8):1283–1288.
39 LaDisa JF, Hettrick DA, Olson LE, Guler I, Gross ER,
Kress TT. Stent implantation alters coronary artery hemody-
namics and wall shear stress during maximal vasodilation. J Appl
Physiol 2002;93(6):1939–1946.
40 Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ,
Leon MB. Axial plaque redistribution as a mechanism of
percutaneous transluminal coronary angioplasty. Am J Cardiol
1996;77:427–430.
41 Chung IM, Gold HK, Schwartz SM, Ikari Y, Reidy MA,
Wight TN. Enhanced extracellular matrix accumulation in
restenosis of coronary arteries after stent deployment. J Am Coll
Cardiol 2002;40(12):2072–2081.
42 Wong JY, Velasco A, Rajagopalan P, Pham Q. Directed
movement of vascular smooth muscle cells on gradient-compli-
ant hydrogels. Langmuir 2003;19(5):1908–1913.
Accepted 21 June 2004
Available online 10 August 2004
